Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutex Health (NUTX) Change in Receivables: 2010-2024

Historic Change in Receivables for Nutex Health (NUTX) over the last 14 years, with FY2024 value amounting to $174.0 million.

  • Nutex Health's Change in Receivables rose 171520.91% to $38.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $217.6 million, marking a year-over-year increase of 293815.97%. This contributed to the annual value of $174.0 million for FY2024, which is 471357.11% up from last year.
  • Nutex Health's Change in Receivables amounted to $174.0 million in FY2024, which was up 471357.11% from $3.6 million recorded in FY2023.
  • In the past 5 years, Nutex Health's Change in Receivables ranged from a high of $174.0 million in FY2024 and a low of -$56.6 million during FY2022
  • For the 5-year period, Nutex Health's Change in Receivables averaged around $39.5 million, with its median value being $5.4 million (2021).
  • In the last 5 years, Nutex Health's Change in Receivables skyrocketed by 6394926.19% in 2020 and then tumbled by 114999.42% in 2022.
  • Annual analysis of 5 years shows Nutex Health's Change in Receivables stood at $71.2 million in 2020, then crashed by 92.43% to $5.4 million in 2021, then plummeted by 1149.99% to -$56.6 million in 2022, then skyrocketed by 106.38% to $3.6 million in 2023, then soared by 4713.57% to $174.0 million in 2024.
  • Its Change in Receivables stands at $174.0 million for FY2024, versus $3.6 million for FY2023 and -$56.6 million for FY2022.